IL311879A - Method for producing compound or pharmaceutically acceptable salt thereof - Google Patents
Method for producing compound or pharmaceutically acceptable salt thereofInfo
- Publication number
- IL311879A IL311879A IL311879A IL31187924A IL311879A IL 311879 A IL311879 A IL 311879A IL 311879 A IL311879 A IL 311879A IL 31187924 A IL31187924 A IL 31187924A IL 311879 A IL311879 A IL 311879A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- crystal
- synthesizing
- reaction
- scheme
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021164171 | 2021-10-05 | ||
| PCT/JP2022/037098 WO2023058645A1 (ja) | 2021-10-05 | 2022-10-04 | 化合物又はその薬学的に許容される塩の製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL311879A true IL311879A (en) | 2024-06-01 |
Family
ID=85803498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL311879A IL311879A (en) | 2021-10-05 | 2022-10-04 | Method for producing compound or pharmaceutically acceptable salt thereof |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240262805A1 (https=) |
| EP (1) | EP4414362A4 (https=) |
| JP (1) | JPWO2023058645A1 (https=) |
| KR (1) | KR20240073943A (https=) |
| CN (1) | CN118055925A (https=) |
| AU (1) | AU2022361862A1 (https=) |
| CA (1) | CA3234498A1 (https=) |
| IL (1) | IL311879A (https=) |
| MX (1) | MX2024004049A (https=) |
| TW (1) | TW202330490A (https=) |
| WO (1) | WO2023058645A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116947658B (zh) * | 2023-07-28 | 2025-10-28 | 南通华祥医药科技有限公司 | 一种1-氨基-2-甲基-2-丙醇的合成方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3269772B1 (en) * | 2015-03-10 | 2020-11-11 | Unimatec Co., Ltd. | Fluorine-containing boric acid/pvb composite |
| ES2856125T3 (es) | 2016-02-05 | 2021-09-27 | Ea Pharma Co Ltd | Derivado de sulfonamida y composición farmacéutica que contiene la misma |
| TW201731824A (zh) * | 2016-02-05 | 2017-09-16 | Ea Pharma Co Ltd | α４β７整合蛋白抑制劑 |
| JP2019031449A (ja) * | 2017-08-04 | 2019-02-28 | Ｅａファーマ株式会社 | スルホンアミド誘導体及びそれを含有する医薬組成物 |
-
2022
- 2022-10-04 WO PCT/JP2022/037098 patent/WO2023058645A1/ja not_active Ceased
- 2022-10-04 AU AU2022361862A patent/AU2022361862A1/en active Pending
- 2022-10-04 CA CA3234498A patent/CA3234498A1/en active Pending
- 2022-10-04 TW TW111137652A patent/TW202330490A/zh unknown
- 2022-10-04 EP EP22878513.5A patent/EP4414362A4/en active Pending
- 2022-10-04 JP JP2023552896A patent/JPWO2023058645A1/ja active Pending
- 2022-10-04 MX MX2024004049A patent/MX2024004049A/es unknown
- 2022-10-04 CN CN202280067043.4A patent/CN118055925A/zh active Pending
- 2022-10-04 KR KR1020247014478A patent/KR20240073943A/ko active Pending
- 2022-10-04 IL IL311879A patent/IL311879A/en unknown
-
2024
- 2024-04-02 US US18/624,295 patent/US20240262805A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4414362A4 (en) | 2025-09-03 |
| WO2023058645A1 (ja) | 2023-04-13 |
| CA3234498A1 (en) | 2023-04-13 |
| AU2022361862A1 (en) | 2024-04-18 |
| JPWO2023058645A1 (https=) | 2023-04-13 |
| KR20240073943A (ko) | 2024-05-27 |
| CN118055925A (zh) | 2024-05-17 |
| US20240262805A1 (en) | 2024-08-08 |
| MX2024004049A (es) | 2024-04-25 |
| TW202330490A (zh) | 2023-08-01 |
| EP4414362A1 (en) | 2024-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102985416B (zh) | 制备凝血酶特异性抑制剂的方法 | |
| JP2024503855A (ja) | アミノピリミジン系ｆａｋ阻害剤化合物を合成する方法 | |
| US20220127259A1 (en) | Solid state forms of valbenazine | |
| BR112013000085B1 (pt) | Processos para a preparação de sal de derivado de diamina opticamente ativo | |
| WO2014016740A2 (en) | Improved process for the preparation of pralatrexate | |
| CN107922352B (zh) | 制备蛋白质脱乙酰酶抑制剂的方法 | |
| CN116751136B (zh) | 氧代吡啶类化合物的新型制备方法及关键中间体 | |
| TW202210486A (zh) | 一種製備ｇｌｐ—１受體激動劑的方法 | |
| JPWO2000044770A1 (ja) | 置換フェネチルアミン誘導体 | |
| US20240262805A1 (en) | Method for producing compound or pharmaceutically acceptable salt thereof | |
| JP6862354B2 (ja) | ナイトロジェンマスタード誘導体の調製方法 | |
| CN105732765A (zh) | 丙肝药物维帕他韦的新合成方法 | |
| AU2014236502A1 (en) | Processes for producing Sovaprevir | |
| CN112592384A (zh) | 一种立他司特杂质及其制备方法和去除方法 | |
| JP2002502378A (ja) | グアニジル化試薬 | |
| KR20190044652A (ko) | 인돌 카르복스아미드 화합물을 제조하는 방법 | |
| CN112272665A (zh) | 制备立他司特的方法 | |
| HK40111936A (en) | Method for producing compound or pharmaceutically acceptable salt thereof | |
| CN116730861A (zh) | 氧代吡啶类化合物的新型制备方法及关键中间体 | |
| EP4479396A1 (en) | Process for manufacturing macrocyclic peptides | |
| HK40106397A (zh) | 化合物或其药学上允许的盐的制造方法 | |
| JPS5833877B2 (ja) | ユウキカゴウブツニカンスルカイリヨウ | |
| JPH078855B2 (ja) | スルホニウム化合物 | |
| CN105121417B (zh) | 经取代噻唑基乙酸三乙胺盐的结晶型 | |
| MXPA03000607A (es) | Procedimiento quimico. |